Latest News

Denis-Borsuk-EVLA-UIP

EVLA at different power settings found to have no significant impact...

There is no significant difference in pain and recanalisation for patients undergoing endovenous laser ablation (EVLA) at different power settings, according to the results...

Features

Private equity firm invests in UK centre performing EVLA for varicose...

A private equity firm, Palatine (Manchester, UK), has announced that it has made a “significant investment” into a UK centre—Veincentre—that provides endovenous laser ablation...

Pharmacotherapy for lymphoedema may be on the horizon

While developing specific treatment for primary lymphoedema presents an “enormous” scientific challenge, secondary lymphoedema may prove an easier target, Oliver Lyons writes for Venous...

Videos

 Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain. Dake said: “The 24-month results from the VERNACULAR trial using the BD Venovo stent show absolutely sustained benefit in...

Fedor Lurie

Johann Chris Ragg

Ramesh Tripathi

(Visited 186,632 times, 400 visits today)